Most Recent

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Genetic Connections Among Human Traits

Genetic Connections Among Human Traits

By | May 16, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

image: Sea Star Comeback?

Sea Star Comeback?

By | May 9, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

image: Breast Milk Primes Gut for Microbes

Breast Milk Primes Gut for Microbes

By | May 5, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

2 Comments

image: Another Andrew Wakefield Movie in the Works

Another Andrew Wakefield Movie in the Works

By | May 4, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

10 Comments

image: Most Gut Microbes Can Be Cultured

Most Gut Microbes Can Be Cultured

By | May 4, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

image: Transparency Now

Transparency Now

By | May 1, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | May 1, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

image: Contributors

Contributors

By and | May 1, 2016

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech